Share

February 2021; 11 (1) Research

Equipoise in Management of Patients With Acute Symptomatic Carotid Stenosis (Hot Carotid)

Aravind Ganesh, Luca Bartolini, Ravinder-Jeet Singh, Abdulaziz S. Al-Sultan, David J.T. Campbell, John H. Wong, Bijoy K. Menon
First published February 5, 2020, DOI: https://doi.org/10.1212/CPJ.0000000000000812
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
311

Share

Article Information

vol. 11 no. 1 25-32
DOI: 
https://doi.org/10.1212/CPJ.0000000000000812
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
2163-0402
Online ISSN: 
2163-0933
History: 
  • Received September 4, 2019
  • Accepted December 3, 2019
  • First Published February 5, 2020.

Article Versions

Copyright & Usage: 
© 2020 American Academy of Neurology

Author Disclosures

    1. Aravind Ganesh, MD, DPhil,
    2. Luca Bartolini, MD,
    3. Ravinder-Jeet Singh, MD,
    4. Abdulaziz S. Al-Sultan, MD, FRCPC,
    5. David J.T. Campbell, MD, PhD, FRCPC,
    6. John H. Wong, MD, MSc, FRCSC and
    7. Bijoy K. Menon, MD, MSc, FRCPC
  1. Aravind Ganesh, MD, DPhil,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. (1) University of Calgary Post-Graduate Medical Education (PGME): travel funding for conferences (2) St John's College, Oxford: travel funding, honoraria (3) International Stroke Conference: Junior Investigator grants (4) American Academy of Neurology: Futures in Neurological Research award, resident scholarships

    Editorial Boards:

    1. (1) Neurology Editorial Board, Disputes and Debates, 2018- Present (2) Neurology:Clinical Practice Editorial Board, Practice Current, 2019- Present (3) Neurology Resident & Fellow Section, Editorial Board Member, 2014-2018 (4) Stroke, Editorial Board Member, 2019-present

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. (1) Adkins Research Group: honoraria for research consultation (2) Genome BC: honoraria for research consultation (3) MD Analytics: honoraria for research consultation (4) My Medical Panel: honoraria for research consultation

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. (1) The Rhodes Trust (2) Wellcome Trust

    Stock/Stock Options/Board of Directors Compensation:

    1. (1) SnapDx (2) TheRounds.ca (3) Advanced Health Analytics (AHA Health Ltd)

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Luca Bartolini, MD,
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. Neurology Clinical Practice, Section Editor, 2015 - present

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. Dr. Bartolini reports having received research support from the NINDS Division of Intramural Research.

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. Dr. Bartolini reports receiving grant support from the American Epilepsy Society / Epilepsy Foundation of America

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Ravinder-Jeet Singh, MD,
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical procedures or imaging studies:

    1. Clinical procedure/imaging study: 90%

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Abdulaziz S. Al-Sultan, MD, FRCPC,
    5. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. David J.T. Campbell, MD, PhD, FRCPC,
    6. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. Diabetes Canada, Travel award

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. Alberta Innovates, Clinician-Fellow, 2013-2019

    Research Support, Academic Entities:

    1. O'Brien Institute for Public Health

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  6. John H. Wong, MD, MSc, FRCSC and
    7. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. Vascular stent Stock/Stock Options, Medical Equipment & Materials: Fluid Biotech Inc., 2013-present

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  7. Bijoy K. Menon, MD, MSc, FRCPC
    8. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. Commercial entity. Travel honoraria from Penumbra Inc.

    Editorial Boards:

    1. Editorial Board, Stroke

    Patents:

    1. A provisional patent 62/086077 for triaging systems in ischemic stroke

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other activities:

    1. Dr. Menon BK reports membership of the Steering and Executive Committee, ESCAPE trial that received support from Covidien Inc., Site Principal Investigator, SOCRATES Trial, sponsored by Astra Zeneca.

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. Research funding from 1) Canadian Institute of Health Research, 2) Heart and Stroke Foundation of Canada, 3) Alberta Innovates Health Solutions, 4) Hotchkiss Brain Institute and the 5) Faculty of Medicine, University of Calgary

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. Department of Clinical Neurosciences (AG, R-JS, ASA-S, JHW, BKM), University of Calgary, Canada; Clinical Epilepsy Section (LB), National Institutes of Health, Bethesda, MD; Centre for Urban Health Solutions (DJTC), St. Michael's Hospital, Toronto, Canada; and Department of Medicine (DJTC), Department of Community Health Sciences (DJTC, BKM), Department of Radiology (JHW, BKM), and The Hotchkiss Brain Institute (JHW, BKM), University of Calgary, Canada.
  1. Correspondence
    Dr. Menon docbijoymenon{at}gmail.com
View Full Text

Article usage

Article usage: February 2020 to July 2022

AbstractFullPdfSource
Feb 2020256049Highwire
Mar 202097025Highwire
Apr 202055019Highwire
May 20203405Highwire
Jun 202014004Highwire
Jul 20209807Highwire
Aug 202086013Highwire
Sep 202067013Highwire
Oct 202081010Highwire
Nov 202056018Highwire
Dec 20203809Highwire
Jan 202160018Highwire
Feb 20215605434Highwire
Mar 20212192229Highwire
Apr 2021117713Highwire
May 202112199Highwire
Jun 20216846Highwire
Jul 20215923Highwire
Aug 20217912Highwire
Sep 20215010Highwire
Oct 20216922Highwire
Nov 20215042Highwire
Dec 20213802Highwire
Jan 20226523Highwire
Feb 20227422Highwire
Mar 20224130Highwire
Apr 20225922Highwire
May 20227453Highwire
Jun 20227174Highwire
Jul 20225435Highwire

Cited By...

The Nerve!: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

  • No related articles found.

Topics Discussed

Alert Me